168 related articles for article (PubMed ID: 25151319)
1. A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients.
Takagi H; Umemoto T;
J Am Soc Hypertens; 2014 Aug; 8(8):578-92. PubMed ID: 25151319
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan as a metabolic sartan: the first meta-analysis of randomized controlled trials in metabolic syndrome.
Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
J Am Soc Hypertens; 2013; 7(3):229-35. PubMed ID: 23523138
[TBL] [Abstract][Full Text] [Related]
3. Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials.
Takagi H; Mizuno Y; Yamamoto H; Goto SN; Umemoto T;
Hypertens Res; 2013 Apr; 36(4):368-73. PubMed ID: 23235712
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of randomized trials of telmisartan vs. valsartan therapy for blood pressure reduction.
Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
Hypertens Res; 2013 Jul; 36(7):627-33. PubMed ID: 23344134
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of randomized trials of telmisartan versus losartan for reduction of ambulatory blood pressure.
Takagi H; Niwa M; Mizuno Y; Goto SN; Umemoto T;
Hypertens Res; 2013 Nov; 36(11):959-66. PubMed ID: 23945962
[TBL] [Abstract][Full Text] [Related]
6. Effects of telmisartan on proteinuria or albuminuria: a meta-analysis of randomized trials.
Takagi H; Yamamoto H; Iwata K; Goto SN; Umemoto T;
Int J Cardiol; 2013 Aug; 167(4):1443-9. PubMed ID: 22560941
[TBL] [Abstract][Full Text] [Related]
7. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials.
Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY
J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649
[TBL] [Abstract][Full Text] [Related]
9. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
Suksomboon N; Poolsup N; Prasit T
J Clin Pharm Ther; 2012 Jun; 37(3):319-27. PubMed ID: 21848583
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension.
Xi GL; Cheng JW; Lu GC
Am J Hypertens; 2008 May; 21(5):546-52. PubMed ID: 18437146
[TBL] [Abstract][Full Text] [Related]
12. Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment.
Fuke Y; Fujita T; Satomura A; Wada Y; Matsumoto K
Diabetes Technol Ther; 2010 May; 12(5):393-8. PubMed ID: 20388049
[TBL] [Abstract][Full Text] [Related]
13. Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.
Bahadir O; Uzunlulu M; Oguz A; Bahadir MA
Hypertens Res; 2007 Jan; 30(1):49-53. PubMed ID: 17460371
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of randomized controlled trials of telmisartan for flow-mediated dilatation.
Takagi H; Umemoto T
Hypertens Res; 2014 Sep; 37(9):845-51. PubMed ID: 24718299
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan lowers home blood pressure and improves insulin resistance without correlation between their changes.
Kobayashi K; Ohno Y; Takenaka T; Ikeda N; Okada H; Kanno Y; Suzuki H
Clin Exp Hypertens; 2011; 33(2):100-5. PubMed ID: 21269058
[TBL] [Abstract][Full Text] [Related]
17. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
[TBL] [Abstract][Full Text] [Related]
18. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
Neldam S; Schumacher H; Guthrie R
Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
[TBL] [Abstract][Full Text] [Related]
19. Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.
Pan G; Zhou X; Zhao J
Cardiovasc Ther; 2014 Aug; 32(4):184-8. PubMed ID: 24645740
[TBL] [Abstract][Full Text] [Related]
20. Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity.
Huang GZ; Tang YH; Wang BY; Zhang B; Hu TJ; Zhang L; Zhang XY; Zhong Y
Saudi Med J; 2011 Oct; 32(10):1017-21. PubMed ID: 22008920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
